Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
31 January 2024 | Story Anthony Mthembu | Photo Supplied
Michelle de Lange
Michelle De Lange: The winner of the ‘Elite University Educator’ award announced at the first AICPA & CIMA CGMA Professional Awards Africa ceremony.

The University of the Free State (UFS) has proudly clinched two prestigious awards at the inaugural Chartered Global Management Accountant (CGMA) Leadership Award ceremony. Organised by the Association of International Certified Professional Accountants, comprising AICPA and CIMA, this event recognises the outstanding contributions to the finance and accounting industry on the continent.

Top university accolade

UFS secured the coveted CGMA Leadership Award for ‘Excellent University Partner (Top 10 in Africa).’ This accolade underscores the institution's commitment to advancing the finance and accounting sector. The presentation took place at the awards ceremony held in Johannesburg on 24 November 2023, marking a significant achievement for the UFS.

Prof Frans Prinsloo, Vice-Dean of Learning, Teaching, Innovation, and Digitalisation in the Economic and Management Sciences (EMS) Faculty at the UFS, views the award as a testament to the alignment of the academic programmes with the standards of leading professional accountancy bodies in South Africa, including the Chartered Institute of Management Accountants (CIMA).

Prinsloo stated, “We have worked diligently to align our academic programmes with the requirements of key potential professional bodies, positioning ourselves as an educator of choice. This recognition, alongside our other accreditations, confirms our success in achieving this goal.”

A global educator recognised

Further enhancing the UFS’s recognition, Michelle de Lange, Lecturer in the School of Accountancy and Programme Coordinator of the B.Com Honours in Management Accounting, received the ‘Elite University Educator of the Year Award’ in the CGMA Leadership Award category. Nominated by her students and colleagues, De Lange expressed her honour and surprise at winning, highlighting her commitment to delivering valuable content to her students.

De Lange shared her perspective, stating, “To compete against phenomenal educators was a privilege, and winning signifies that my efforts are making a positive impact on students and colleagues alike.”

According to Prinsloo and De Lange, these accolades affirm the institution’s dedication to producing top-class accountancy and finance graduates.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept